Nacre Capital

Nacre Capital

Global venture builder for deep-tech startups

Overview

Nacre Capital is a global venture builder that creates, builds, and grows disruptive start-ups based on deep technologies. It brings together entrepreneurs, scientists, technologists, researchers, and growth experts to imagine and develop ventures from scratch, guiding ideas from concept to fast-growing, market-leading companies. The team provides end-to-end support—identifying opportunities, building teams, securing resources, and scaling ventures—through an in-house portfolio that targets solutions to complex societal problems with breakthrough deep tech. Unlike typical investment firms, Nacre Capital combines hands-on venture creation with deep technical and domain expertise across an international network. Its goal is to transform novel ideas into world-class companies that deliver significant, lasting impact.

About Nacre Capital

Simplify's Rating
Why Nacre Capital is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Food & Agriculture

AI & Machine Learning

Biotechnology

Healthcare

Company Size

1-10

Company Stage

N/A

Total Funding

N/A

Headquarters

Tel Aviv-Yafo, Israel

Founded

N/A

Get referred to Nacre Capital

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Aquaticode closed a $6 million Series A in August 2022 with Nacre participation.
  • Fairtility raised $15 million Series A in May 2022, validating Nacre’s healthtech thesis.
  • Nacre’s website lists FDNA, Fairtility, Seed-X, Aquaticode, CureSign, and Kinsame.

What critics are saying

  • Nacre Capital lacks visible 2025-2026 financing or hiring data, obscuring momentum.
  • Portfolio concentration in small deeptech bets ties outcomes to clinical, regulatory, and sales cycles.
  • If Fairtility, FDNA, or Seed-X stall, Nacre Capital loses its clearest credibility engine.

What makes Nacre Capital unique

  • Moti Shniberg built Face.com and CyberMDX, proving repeatable company creation.
  • Nacre Capital operates as a venture builder, not a passive fund, adding execution leverage.
  • Its portfolio targets deep-AI niches: fertility, rare disease, seeds, aquaculture, and cybersecurity.

Help us improve and share your feedback! Did you find this helpful?

Company News

ApkaHindiBlog
Aug 30th, 2022
Aquaticode Closes USD6M Series A Funding » ApkaHindiBlog

AquaticodeIn its first round of external financing, 6M USD was raised by, a Stavanger-based technology developer that boosts global seafood production.

FinSMEs
May 24th, 2022
Fairtility Closes $15M Series A Funding

Fairtility, a Tel Aviv Israel-based transparent AI innovator powering in vitro fertilization (IVF), closed a $15 million Series A funding round. The round, which brings total funding to $18.5m to date, was led by Gurnet Point Capital, and included Nacre Capital and additional investors. The company intends to use the funds to advance clinical research with fertility clinics and academic [] The post Fairtility Closes $15M Series A Funding appeared first on FinSMEs.

Recently Posted Jobs

Sign up to get curated job recommendations

Nacre Capital is Hiring for 3 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →